There is a real sense that we are on the cusp of a diagnostics revolution. This has been spurred on by the pandemic, which at once underscored the tremendous power of mass testing as it became the fundamental basis for decision-making, from our own personal health to national policy. It also revealed gaps in terms of needing to drastically scale up testing capacity and invest in new and innovative digital diagnostics tools.
Innovation in diagnostics, however, is not just vital to advancing disease surveillance and early detection to help prevent the next pandemic. It will be the enabling tool towards a much more preventive and proactive approach to healthcare across the board, improving individual patient outcomes and the health and well-being of entire communities globally.
